Koo nothing has come of it because we know we have something pretty exciting here and we want to receive fair value, to this point in time we have not been offered that "fair value". Should DM and the board be selling for less than they or we value it at?

There are many ways to structure a sale.

It can be a complete sale of all assets and all IP.

It can be for certain IP, example all molecules related to Apabetalone. Spun out into a newco and Resverlogix retains the balance of IP.

It can include future milestone payments.

It can include royalties.

It could be a joint venture or partnership

Or... a combination of the above.

Or as you said, licensing. We could retain ownership of the IP and negotiate licence agreements.

There are many ways a deal can be structured to account for present value(negotiated between buyer and seller to mutually agreed present value at this time) with future milestone payments(future value) at specific dates(provided our drug development continues to progress to AFD approval)

It could be structured with present value and future royalties once AFD approved.

It could be a sale for cash or shares of buyers company.

Depending on the outcome, shareholders might receive cash, dividend, shares of buyers company, or some other payment arrangement.

There are many of us invested that have been around a long time and are interested in the financial reward for sticking with this investment but some(many) want to enjoy their reward and not leave it to their heirs!